2010-12-06 00:00:00,Celgene Corporation Announces Updated Clinical Results From REVLIMID Continuous Treatment Phase III Study
2010-12-07 00:00:00,Celgene Celgene International Srl Announces Data From Three Presentations Evaluating Clinical Benefit Of Pomalidomide In Previously Treated Multiple Myeloma
2011-01-10 00:00:00,Celgene Corporation Issues FY 2011 EPS Below Reaffirms FY 2010 Revenue Sees FY 2010 EPS At High End Of Prior Guidance
2011-01-27 00:00:00,Celgene Corporation Reaffirms FY 2011 Call
2011-06-02 00:00:00,Celgene Corporation And Acceleron Initiate Phase Study Of To Treat Anemia In Patients With Lung Cancer
2011-06-17 00:00:00,FDA Grants Accelerated Approval of Celgene ISTODAX As Treatment for Patients with Peripheral Lymphoma Who Have Received at Least One Prior Therapy
2011-07-28 00:00:00,Celgene Corporation Raises FY 2011 Guidance
2011-08-18 00:00:00,Celgene Corporation Announces Additional Billion Share Repurchase Authorization
2011-11-04 00:00:00,Celgene Corporation Enters Into Strategic Cancer Drug Discovery Collaboration With Quanticel Pharmaceuticals
2011-11-11 00:00:00,Celgene Corporation Revises FY 2011 Revenue Guidance To A Range Above Revises FY 2011 EPS Guidance To A Range Below Call
2011-11-21 00:00:00,Celgene Celgene International Srl Announces Approval for Treatment of Rare Blood Cancer
2011-11-22 00:00:00,Celgene Corporation Announces Discontinue Phase III MAINSAIL Trial in Prostate Cancer
2012-02-09 00:00:00,Celgene Corporation Announces USD15 Million Strategic Equity Investment In Acetylon Pharmaceuticals
2012-04-26 00:00:00,Epizyme Forms Strategic Partnership With Celgene Celgene International Srl
2012-06-05 00:00:00,Celgene Celgene International Sarl Presents Results of Study into Use of ABRAXANE Combined with Gemcitabine in the Treatment of Resectable Pancreatic Cancer
2012-06-13 00:00:00,Celgene Corporation Announces Additional Billion Share Repurchase Program
2012-06-21 00:00:00,Celgene Corporation Reaffirms FY 2012 And FY 2015 Comments On FY 2013 EPS Call
2012-07-12 00:00:00,Celgene Celgene International Srl Announces Results Of Phase III Study In Patients With Psoriatic Arthritis
2012-10-19 00:00:00,Celgene Corporation Trade Flow Review
2012-10-23 00:00:00,Independent Monitor Says Celgene Corp Cancer Drug Meets
2012-10-24 00:00:00,Wells Fargo Securities Reiterates Outperform on Celgene
2012-10-25 00:00:00,Celgene Corp Raises FY 2012 EPS Narrows FY 2012 Revenue Guidance To A Range In Line With Estimates
2012-10-26 00:00:00,Factors of Economy and Policy Research Analysis on Celgene
2012-11-05 00:00:00,FDA Considering Faster Approval Process for Developers of Drugs for Deadly or
